Journals / Türkiye Çocuk Hastalıkları Dergisi / 2012 / Cilt: 6 - Sayı: 2

PREVENTATIVE STRATEGIES IN NECROTIZING ENTEROCOLITIS

Nekrotizan Enterokolitte Önleyici Tedavi Seçenekleri

Pages
121–128
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The development of standard guidelines is required in the prevention of NEC

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Necrotizing enterocolitis (NEC) is the most serious disease of newborn gastrointestinal tract.
📊
Key Findings & Data:NEC affects 5-10% of very low birth weight infants.
💡
Conclusion & Impact:The development of standard guidelines is required in the prevention of NEC
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Nekrotizan enterokolit · önleyici tedaviler · Necrotizing enterocolitis

Abstract

Necrotizing enterocolitis (NEC) is the most serious disease of newborn gastrointestinal tract. NEC affects 5-10% of very low birth weight infants. It is one of the most common causes of mortality and morbidity in neonatal intensive care units. Although pathogenesis of the disease is not clear, prematurity and low birth weight are the most significant risk factors. Poor prognosis of NEC could not be changed with current therapies. However, some preventive strategies can be used in the antenatal and postnatal period. Decreasing the incidence of premature births or poor fetal growth would have a major effect on the prevalence of NEC. Breast feeding and antenatal steroid therapy seem to be preventive for NEC. Although oral antibiotics seem to be effective, their safety is unclear. New studies are required with arginin supplementation. Prebiotics do not appear to be of benefit in prevention of NEC. Although probiotics seem to be effective, optimum strain, duration of supplementation, dose and safety in critically ill infants are the questions that have to be answered. The development of standard guidelines is required in the prevention of NEC

Özet

Nekrotizan enterokolit, yenidoğanları etkileyen en ciddi gastrointestinal sistem hastalığıdır. Çok düşük doğum ağırlıklı bebeklerin %5-10’unda görülmektedir. Yenidoğan yoğun bakım ünitelerindeki mortalite ve morbiditenin en sık nedenlerinden biridir. Hastalığın patogenezi tam olarak bilinmemekle beraber, prematürite ve düşük doğum ağırlığı en önemli risk faktörleridir. Güncel tedavi şemaları ile nekrotizan enterokolitin olumsuz gidişatı değiştirilememektedir. Bununla birlikte antenatal ve postnatal dönemde birtakım önlemler alınabilmektedir. Prematüre doğumların ve fetal gelişme geriliğinin azaltılması nekrotizan enterokoliti önlemede önemli role sahiptir. Antenatal steroid kullanımı ve anne sütü ile beslenme nekrotizan enterokolitten korunmada etkili gözükmektedir. Oral antibiyotikler etkili gözükse de güvenilirlikleri kanıtlanmamıştır. Beslenmeye arginin eklenmesi ile yapılacak yeni çalışmalara ihtiyaç vardır. Prebiyotiklerin nekrotizan enterokolitten korunmadaki etkileri kesin değildir. Probiyotikler etkili bulunmakla birlikte doz, zamanlama, tür ve riskli bebeklerde kullanımıyla ilgili cevaplanması gereken sorular mevcuttur. Nekrotizan enterokolitten korunmada standart kılavuzların geliştirilmesine gerek vardır.

🔖

Cite This Article

DİLMEN, U., SARI, F. N. (2022). PREVENTATIVE STRATEGIES IN NECROTIZING ENTEROCOLITIS. Türkiye Çocuk Hastalıkları Dergisi, Cilt: 6 - Sayı: 2, 121–128. https://ajindex.com/articles/627583

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Lin PW, Nasr TR, Stoll BJ. Necrotizing enterocolitis: recent scien- tific advances in pathophysiology and prevention. Semin Perinatol 2008;32(2):70-82.
  2. Deshpande G, Rao S, Patole S. Probiotics for prevention of nec- rotising enterocolitis in preterm neonates with very low birthwe- ight: a systematic review of randomised controlled trials. Lancet 2007;369(9573):1614-20.
  3. Embleton ND, Yates R. Probiotics and other preventative stra- tegies for necrotising enterocolitis. Semin Fetal Neonatal Med 2008;13(1):35-43. Stoll BJ. Epidemiology of necrotizing enterocolitis. Clin Perinatol 1994;21(2):205-18.
  4. Rowe MI, Reblock KK, Kurkchubasche AG, Healey PJ. Necroti- zing enterocolitis in the extremely low birth weight infant. J Pedi- atr Surg 1994;29(8):987-90.
  5. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006; 368(9543):1271-83.
  6. Schulzke SM, Deshpande GC, Patole SK. Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing ente- rocolitis: a systematic review of observational studies. Arch Pedi- atr Adolesc Med 2007;161(6):583-90.
  7. Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez- Crussi F. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003;6(1):6-23.
  8. Dai D, Nanthkumar NN, Newburg DS, Walker WA. Role of oligo- saccharides and glycoconjugates in intestinal host defense. J Pedi- atr Gastroenterol Nutr 2000;30 Suppl 2: 23-33.
  9. Costalos C, Kapiki A, Apostolou M, Papathoma E. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum Dev 2008;84(1):45-49. Caplan M. Neonatal necrotizing enterocolitis. In: Martin RJ, Fana- roff AA, Walsh MC, eds. Fanaroff and Martin’s Neonatal-Perinatal Medicine. Philadelphia: Mosby 2006:1403-10.
  10. Dorling J, Kempley S, Leaf A. Feeding growth restricted prematu- re infants with abnormal antenatal Doppler results. Arch Dis Child Fetal Neonatal Ed 2005;90(5):359-63.
  11. Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid ad- ministration before premature delivery: an overview of the eviden- ce from controlled trials. Br J Obstet Gynaecol 1990;97(1):11-25.
  12. Smith LM, Qureshi N, Chao CR. Effects of single and multiple co- urses of antenatal glucocorticoids in premature newborns less than 30 weeks’ gestation. J Maternal Fetal Med 2000;9(2):131-5.
  13. Kenyon SL, Taylor DJ, Tarnow-Mordi W; ORALLE Collaborati- ve Group. Broad-spectrum antibiotics for preterm, prelabour rup- ture of fetal membranes: the ORACLE I